With two COVID-19 vaccine candidates proving to be more than 90% effective from preliminary late-stage trials, market sentiment got a notable boost in recent sessions. Jacob Doo, CIO of Envysion Wealth Management, joined us on Prime Time to discuss how this might impact markets that are hungry for hope, and advice he might give clients amidst signs of a rotation from tech and growth towards value stocks.

<p>With two COVID-19 vaccine candidates proving to be more than 90% effective from preliminary late-stage trials, market sentiment got a notable boost in recent sessions. Jacob Doo, CIO of Envysion Wealth Management, joined us on Prime Time to discuss how this might impact markets that are hungry for hope, and advice he might give clients amidst signs of a rotation from tech and growth towards value stocks.</p>

Advertisement